Here are four things to know:
1. Merck and Premier first partnered in 2016 to co-develop and test healthcare improvement solutions for specific groups of at-risk patients.
2. Under the new initiative, the companies will create a software-based platform to offer surveillance, consultation, support and education to C. diff patients, in conjunction with a care coordinator.
“The goal is to increase patient access to healthcare services, raise awareness of how to decrease patient risk of recurrence and help patients identify if they are having a recurrence,” said Premier.
3. Merck and Premier will test the improvement initiative at participating Premier member health systems.
4. Financial terms of the deal were not disclosed.
More articles on clinical leadership and infection control:
Obese hospital patients less likely to die from sepsis, study finds
Viewpoint: Why state-mandated nurse ratios could harm patient safety
Missouri heart attack patients now sent to best-equipped hospital — not always the closest
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
